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ABSTRACT We have investigated the action of procainamide on batrachotoxin (BTX)-activated sodium channels from bovine
heart and rat skeletal muscle. When applied to the intracellular side, procainamide induced rapid, open-channel block. We
estimated rate constants using amplitude distribution analysis (Yellen, G. 1984. J. Gen. Physiol. 84:157). Membrane depo-
larization increased the blocking rate and slowed unblock. The rate constants were similar in both magnitude and voltage
dependence for cardiac and skeletal muscle channels. Qualitatively, this block resembled the fast open-channel block by
lidocaine (Zamponi, G. W., D. D. Doyle, and R. J. French. 1993. Biophys. J. 65:80), but procainamide was about sevenfold less
potent. Molecular modeling suggests that the difference in potency between procainamide and lidocaine might arise from the
relative orientation of their aromatic rings, or from differences in the structure of the aryl-amine link. For the cardiac channels,
procainamide reduced the frequency of transitions to a long-lived closed state which shows features characteristic of inactivation
(Zamponi, G. W., D. D. Doyle, and R. J. French. 1993. Biophys J. 65:91). Mean durations of kinetically identified closed states
were not affected. The degree of fast block and of inhibition of the slow closures were correlated. Internally applied QX-314,
a lidocaine derivative and also a fast blocker, produced a similar effect. Thus, drug binding to the fast blocking site appears to
inhibit inactivation in BTX-activated cardiac channels.
INTRODUCTION
We have recently described the action of lidocaine on BTX-
activated sodium channels from heart and skeletal muscle
(Zamponi et al., 1993a, b). Here, we investigate the action
of procainamide on the two channel subtypes. The electro-
physiological effects of procainamide on the cardiac action
potential have been observed since the 1950s (Weidmann,
1955) and extensively studied (e.g., Rosen et al., 1972;
1973), however, some of the results are controversial (e.g.,
whether procainamide blocks the open or the inactivated
state; (Sada et al., 1979; Ehring et al., 1988)). However, there
has been no attempt to identify different blocking modes or
to describe state dependence of procainamide action.
The purpose this paper is to compare the blocking action
of lidocaine with the structurally similar procainamide. We
recently presented evidence that BTX-activated cardiac so-
dium channels show some residual inactivation which ap-
pears as a distinct population of long gating closures with
mean closed times of 150-600 ms (Zamponi et al., 1993b).
Thus, this channel type constitutes an excellent model for the
study of state-dependent interactions between the sodium
channel and antiarrhythmic agents. For lidocaine, binding of
the uncharged form of the drug to this residual inactivated
state resulted in pronounced slow block (mean blocked du-
rations generally greater than 1 s (Zamponi et al., 1993b)).
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In contrast, the charged form of lidocaine caused fast, open
channel block with mean blocked times of less than 1 ms
(Zamponi et al., 1993a). A comparison of the potency and
state dependence of block by various class 1 antiarrhythmic
agents may help to identify structural parts of the drugs which
are involved in binding and, hence, provide valuable clues
about the nature of the class I antiarrhythmic receptor. How-
ever, since the presence of batrachotoxin affects ion selec-
tivity, single channel conductance (e.g., Quandt et al., 1982;
Garber and Miller, 1987; Correa et al., 1991) and affinity for
local anesthetics (e.g., Khodorov et al., 1975), it is important
to remember that the properties of BTX-activated channels
are altered when extrapolating our data to unmodified
sodium channels.
Procainamide induces rapid, flickery block of both chan-
nel subtypes. The rate constants for blocking and unblocking
were estimated using the amplitude distribution analysis in-
troduced by Yellen (1984). Procainamide block is qualita-
tively similar to fast lidocaine block. Block from the intra-
cellular side probably occurs via a hydrophilic route, while
from the extracellular side, procainamide may approach the
receptor via a direct, hydrophobic pathway. The equilibrium
dissociation constant for procainamide block measured at 0
mV, however, was sevenfold larger than that for lidocaine
block. Procainamide also appeared to be capable of the type
of slow block effected by lidocaine, but only at very high
concentrations (>100 mM). This is consistent with the
low concentration of the uncharged form of procainamide
(pKa = 9.1) present at a pH of 7.0. A more pronounced effect
of procainamide on the "inactivation" events was a reduction
in their frequency. Kinetic analysis indicated that this re-
duction was correlated with the binding of procainamide to
the fast block receptor. We observed similar effects of fast
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block by QX-314 and lidocaine. Our data suggest that bind-
ing to the fast block receptor inhibits, either directly or al-
losterically, inactivation in BTX-activated cardiac sodium
channels.
METHODS
Membrane preparations
Membrane vesicles from bovine cardiac and rat skeletal muscle tissue were
prepared and incubated with BTX as previously described (Zamponi et al.,
1993a). Protein concentrations were 5.4 and 6.2 mg/ml for rat skeletal
muscle membranes from two preparations, and 3.5 mg/ml for bovine cardiac
membranes from one preparation.
Bilayer methods and single channel recordings
Bilayers, made of a decane solution of uncharged synthetic lipids (40 mg/ml
1-palmitoyl-2-oleoylphosphatidylethanolamine, 10 mg/ml 1-palmitoyl-2-
oleoylphosphatidylcholine in decane), were formed on a planar plastic par-
tition (made from a microscope coverslip, cat. no. 12-547, Fisher Scientific
Co., Pittsburg, PA) separating two chambers, each containing 1.5 ml of 200
mM NaCl and 20mM 3-N-morpholinopropanesulfonic acid (MOPS) at pH
7.0 at room temperature (-22°C). Holes were constructed as described in
Wonderlin et al. (1990), all experiments were performed with a hole di-
ameter of 130 gm. The total capacitance was in the range of 50-80 pF.
Between 2 and 20 ,ul of membranes were added to the cis side which was
continuously stirred. Voltages were alternated between +70 and -70 mV,
until channel incorporation was indicated by an increase in membrane con-
ductance. The gating voltage dependence of the channels was used to de-
termine their orientation in the bilayer (Krueger et al., 1983). Cardiac chan-
nels generally were oriented with the cytoplasmic end facing the cis
chamber, skeletal muscle channels usually were in reverse orientation. Re-
cordings were limited to single channel incorporations. Bilayers were volt-
age clamped as described previously (Zamponi et al., 1993a). The duration
of the recordings (10-80 min) was determined by the stability of the bilayers.
Chemicals and solutions
For most experiments, procainamide (purchased from Aldrich Chemical
Co., Milwaukee, WI) was dissolved in water to make a stock solution of 200
mM. The pH was adjusted to 7.0 with NaOH. The drug solution was usually
added to the chamber facing the intracellular side of the channel. External
application of the drug required 20-fold higher concentrations for block.
Thus, we prepared a stock solution of 300 mM procainamide and 200 mM
NaCl at a pH of 7.0 which allowed us to apply high concentrations (up to
100 mM) of the drug without altering ionic conditions. Both stock solutions
produced identical effects when added intracellularly to give 20 mM pro-
cainamide. QX-314 was dissolved in water to give a stock solution of 200
mM. Lidocaine and MOPS were dissolved in water to make a stock of 200
mM lidocaine/200 mM MOPS at pH 6.7.
Data analysis
For experiments involving internal or external fast block, data were acquired
for up to 1 min at each voltage. Because we were unable to resolve the fast
blocking events as discrete steps, we used the amplitude distribution analysis
introduced by Yellen (1984) to analyze fast block. The analysis was imple-
mented as described for fast lidocaine block (Zamponi et al., 1993a).
To study the effect of procainamide, QX-314, and lidocaine, on the
long gating closures for the cardiac subtype, slow gating events were re-
corded in continuous records of up to 20 min. Data were filtered at 200
Hz and sampled at 500 Hz during transcription, and digitally filtered at
25 Hz to create events lists in pCLAMP version 5.5 (Axon Instruments
Inc., Foster City, CA). For studies of open times, closed events shorter
than 70 ms were ignored to eliminate contributions from fast gating and
blocking events. For generation of closed time histograms we did not ig-
nore events, however, filtering at 25 Hz eliminates events shorter than 7
ms (McManus et al., 1987). We did not correct for missed events.
Dwell time distributions and amplitude histrograms were generated and
fitted in pCLAMP, preparation of figures and all other fits were conducted
in Sigmaplot (Jandel Scientific, Corte Madera, CA).
Molecular modeling
The MACROMODEL software package (Mohamadi et al., 1990), based on
the AMBER (Weiner et al., 1984) molecular mechanics force field and
extensions to it, was used to search for low energy conformations of lido-
caine and procainamide. Calculations were simplified by considering only
the key inner fragments of each molecule. Specifically, methyl rather than
ethyl groups were attached to the tertiary nitrogen atoms, and for procain-
amide, the para -NH2 moiety was omitted. Usage-directed Monte Carlo
searching of conformational space was used to examine 3000 conformers
with tabulation of those conformers within 50 kJ-mol-1 of the lowest energy
structure.
RESULTS
Procainamide causes fast block
In the absence of blockers, BTX-activated sodium channels
generally show a constant open probability (Popen > 0.5) at
potentials more positive than about -60 mV. Figs. 1, A and
B, show examples of records in absence and presence of
procainamide for both bovine cardiac and rat skeletal muscle
sodium channel subtypes. BTX-activated cardiac sodium
channels generally show a distinct population of long,
trypsin-sensitive gating closures (Zamponi et al., 1993b)
with mean durations ranging from 150 to 600 ms. A typical
example is the closed event at +40 mV. These types ofgating
events are only rarely seen for the skeletal muscle subtype.
For both subtypes, addition of 12mM procainamide resulted
in a reduction in apparent single channel amplitude and an
increase in open channel noise. As can be clearly seen from
the records, the effect was more pronounced at depolarizing
potentials. The apparent increase in noise is probably caused
by blocked events that, at a bandwidth of 50 Hz, are not
resolved as discrete transitions from the open to the closed
state. Block appears as a flickery open state, with a reduced
apparent single channel amplitude and a broadened ampli-
tude distribution. This can clearly be seen in Fig. 1 C. In
absence of blockers, the normalized amplitude distribution is
comprised of two Gaussians representing the open (defined
as 1) channel and the baseline (defined as 0) amplitudes. In
presence of 12 mM procainamide (middle panel), the mean
current amplitude is decreased and the apparent open channel
noise is increased, as shown by a leftward shift and broad-
ening of the peak representing the open channel. This be-
comes more obvious when the peak representing the baseline
is subtracted (bottom panel). Assuming a two state, open-
blocked model, the shape of the remaining histogram may be
described theoretically by the filter output density function
of Yellen (1984):
ya 1(1 - y)b_l
fly) = fya-l(l - y)bl dy)
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FIGURE 1 Current traces recorded from single BTX-activated sodium channels from (A) bovine heart and (B) rat skeletal muscle in absence and presence
of procainamide. In absence of the drug both channel types are open most of the time at potentials more positive than -60 mV. Procainamide, applied to
the intracellular side, acts similarly on both channel subtypes by inducing rapid blocking events. At the illustrated bandwidth of 50 Hz the fast blocking
events were not resolved as discrete, rectangular steps, but rather appear as an increase in open channel noise with a concomittant decrease in the apparent
single channel current amplitude. The solid lines indicate the closed level. Note that the traces for the cardiac subtype at +40 mV and -40 mV were recorded
from two different bilayers with different baseline noise. (C) Amplitude distributions for the same cardiac channel traces at +40 mV as in A. In absence
of procainamide, the normalized amplitude distribution shows two Gaussian-distributed peaks (upper panel). Here, the open level has been defined as 1,
and the closed level as 0. In presence of 12 mM procainamide (middle panel), the apparent single channel amplitude is decreased and the open channel
noise is increased. Hence, in the amplitude distribution this appears as a broadening and shift of the the open level peak toward smaller amplitudes. After
subtraction of the baseline (lower panel), the remaining peak is fitted with the filter output density function outlined under Results. The fit shown in this
panel yielded blocking and unblocking rates of 6487/s and 7018/s, respectively.
This, when convolved with a Gaussian function describing
the baseline noise and then fitted to the amplitude distribution
as shown in the bottom panel, provides estimates for the
association and dissociation rate constants of the blocker
(kon = aiT, koff = biT with T = 0.228/f, where f is the fre-
quency at 3-dB attenuation for an eight-pole Bessel filter, and
0.228 is an empirically determined constant (Yellen, 1984)).
We have recently used this type of analysis to determine
blocking and unblocking rate constants for lidocaine
(Zamponi et al., 1993a).
Procainamide block is voltage-dependent and
similar for both channel subtypes
Fig. 2 shows the voltage dependences of the individual rate
constants and the equilibrium dissociation constants of in-
ternally applied procainamide for both channel subtypes. The
blocking rate was favored by depolarizing potentials (Fig. 2
A) which is consistent with a positively charged blocker en-
tering the transmembrane voltage from the cytoplasmic side
of the channel. Unblock was enhanced at negative voltages
(Fig. 2B) as expected for a positively charged blocker exiting
the internal mouth of the channel down the electric potential
gradient. Since the equilibrium dissociation constant (Kd) is
determined by the ratio of unblocking to blocking rate, it
decreased with more positive potentials (Fig. 2 C). The volt-
age dependence of theKd suggests that the positively charged
amine group located at the procainamide tail penetrates the
transmembrane voltage 43% (for the cardiac subtype) and
31% (for the skeletal muscle subtype) from the cytoplasmic
end of the channel (Woodhull, 1973). Both channel subtypes
appeared to show similar rate constants for procainamide
block.
The similar effect of internal procainamide on the chan-
nels from both tissues is also illustrated in Fig. 3. Fig. 3 A
shows dose response curves at +40 mV. The open prob-
ability (the probability that a channel is not blocked while
in an open gated state) was calculated from the rate con-
stants. Note that this definition contrasts with the defini-
tion of open probability used in the analysis of slow gating
gating events later in this paper. The fast-block data were
fitted with a first order hyperbola suggesting a 1:1 inter-
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FIGURE 2 Voltage dependence of the rate constants and equilibrium dis-
sociation constant for internal procainamide block of bovine cardiac
(circles, solid lines, downward error bars, six experiments) and rat skeletal
muscle (triangles, dashed lines, upward error bars, six experiments) so-
dium channels. Rate constants were obtained using the amplitude distri-
bution analysis introduced by Yellen (1984). Lines are least square fits, error
bars indicate standard deviations. (A) The block rates increase with depo-
larization, consistent with the idea of a positively charged blocker entering
the transmembrane electric field from the cytoplasmic end of the channel
(cardiac: (ZS).n = 0.18, skeletal: (ZS).n = 0.11). (B) The unblock rates
increase with hyperpolarization (cardiac: (z8)off = 0.25, skeletal: (Z8)off =
0.21). (C) The equilibrium dissociation constant, Kd, is calculated from the
ratio of unblock to block rate (Kd = k0ff/k0n). The voltage dependences of
the Kd values (cardiac, z8 = 0.43; skeletal, zb = 0.31) suggest binding sites
located 43 and 31% of the way across the transmembrane voltage from the
cytoplasmic end of the channel, for the cardiac and the skeletal muscle
subtypes, respectively.
action between the blocker and its binding site. The con-
centrations required to block the channel half of the time
(14.9 mM for the cardiac subtype, 19 mM for the skeletal
muscle subtype) are consistent with the Kd values obtained
from Fig. 2 C.
To test the voltage dependence of procainamide indepen-
dently ofthe assumptions ofthe amplitude distribution analy-
sis, we calculated the voltage-dependent reduction in mean
current in the presence of 12 mM procainamide. The results
0
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FIGURE 3 (A) Dose response curves for block of bovine cardiac and rat
skeletal muscle sodium channels by internally applied procainamide at +40
mV. The open probability, Popen, was calculated from the rate constants as
follows: Ppen = koff/(k0n + k0ff). Data points from skeletal muscle (upward
error bars, six experiments) and heart (downward error bars, six experi-
ments) were fitted with a first order hyperbolaPop0n = 1/(1 + [P]/Kd), where
[P] is the drug concentration and Kd is the equilibrium dissociation constant.
The Kd values obtained from the fit are 19.0 mM for the skeletal muscle and
14.9 mM for the cardiac subtype. Error bars indicate standard deviations.
(B) The voltage dependence of procainamide block was also directly de-
termined from the reduction in apparent single channel amplitude. The data
were fitted with a Boltzmann relation I/I(drug free) = 1/(1 + exp{zS
(V - VH)/25.4}), where V is the membrane potential, VH is the potential at
half block and zS is proportional to the slope of the fit (c.f. Woodhull, 1973).
The zS values obtained from the fits suggest that the procainamide binding
sites are located 38 and 30% of the way through the transmembrane voltage
for the cardiac and the skeletal muscle subtype respectively. These data are
consistent with the results obtained from amplitude distribution analysis and
illustrated in Fig. 2 C. Symbols, error bars and number of experiments are
as described in A.
are presented in Fig. 3 B. The data points were fitted with a
Boltzmann relation, the steepness of the slope indicates
electrical distances of 0.38 and 0.30 for the cardiac and the
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skeletal muscle subtypes, respectively. These values are
close to those obtained from Fig. 2 C.
Block from the extracellular side is weak
In a clinical setting, antiarrhythmic drugs approach the target
cell from the extracellular medium. They can then act di-
rectly from the extracellular side (Alpert et al., 1989;
Baumgarten et al., 1991) or pass through the cell membrane
to act via a membrane-delimited pathway (Zamponi et al.,
1993a; Hille, 1977a, b) or from the intracellular side (Hille
1977a, b; Strichartz, 1976). We therefore applied the drug to
the chamber facing the extracellular side of the membrane.
We did not observe any block at concentrations around the
Kd for internal fast block. At concentrations of 100 mM, the
apparent single channel amplitude was reduced by 25% at
+80 mV and by about 10% at -70 mV for the cardiac sub-
type. We did not attempt to expose the channel to higher drug
concentrations. At +40 mV, data from 2 experiments suggest
an apparent Kd for external block of approximately 400 mM.
In addition, block appeared to be less voltage-dependent than
for internal application (z6 = 0.17 for equilibrium block,
from one cardiac channel). In general, the increase in ionic
strength on the extracellular side due to the large drug con-
centrations resulted in a shift of the steady state activation
curve toward more depolarizing potentials for both channel
types. For the channels in these experiments, the midpoint of
the steady-state activation curve for the muscle subtype oc-
curred at more positive potentials than that of the cardiac
channels. Hence, the increase in ionic strength on the ex-
tracellular side resulted in rapid gating transitions for the
skeletal muscle subtype at potentials more negative than -50
mV, making a quantitative analysis of fast block impossible.
Because of more negative midpoints of the steady state ac-
tivation curves, some analysis was possible for the cardiac
channels, as described above.
Procainamide antagonizes long gating closures
of the cardiac subtype
Cardiac sodium channels, unlike the skeletal muscle subtype,
show a distinct population of long closures with time con-
stants between 150 and 600 ms (French et al., 1990). This is
illustrated in Fig. 4 A. The single channel record and the
corresponding dwell time histogram showed at least two dis-
tinct types of closures, a short-lived closed state on the order
of 20 ms and a longer closed state with a mean time of about
330 ms. In the presence of procainamide (nine experiments),
the frequency of the long closures was reduced, as can be
seen from the record in Fig. 4 B and the smaller peak (tC2)
in the corresponding dwell time histogram. The duration of
the long gating events was not affected by the drug.
Fig.5A demonstrates that the time between the long gating
events increased linearly with procainamide concentration.
For this analysis, events shorter than 70 ms were ignored,
thus, the open and the fast blocked states as well as the the
short-lived gating closures between successive long closures
are combined as a single "open" state (see also Zamponi
et al., 1993b). Only the long gating events appeared as clo-
sures. According to our kinetic model presented in the Dis-
cussion, the slope of the regression line reflects the Kd for fast
internal procainamide block. The value obtained from this fit
(17.9 mM) is close to the 14.9 mM obtained from the dose
response curve for fast block in Fig. 3 A. Procainamide did
not affect the mean duration of the long gating closures (Fig.
5 B). The closed times were obtained from fits to dwell time
histograms as in Fig. 4, A and B, and here, no events were
ignored during the analysis. Our data suggest that a cardiac
channel is unable to enter the long closed state when blocked
by procainamide and that the drug neither binds to, nor en-
hances recovery from, this state.
We have previously shown that lidocaine caused pro-
nounced slow blocking events at millimolar concentrations
FIGURE 4 Long gating closures of the bovine cardiac
sodium channel are inhibited by procainamide. Histo-
grams are in the form devised by Sigworth and Sine
(1987). All data were recorded at +40 mV, traces were
filtered at 25 Hz, solid lines indicate the closed level. (A)
An example of a typical single channel record from a
BTX-activated cardiac sodium channel (closures are
downward deflections) and the corresponding closed
time histogram. In absence of the drug, the closed time
distribution shows at least two distinct populations of
closures (time constants tc, = 20 ms, tc2(drug free) =
332 ms). The longer closures are characteristic for the
cardiac subtype (Zamponi et al., 1993b). (B) Procain-
amide (12 mM), applied to the intracellular side,
causes a reduction in the frequency of the long clo-
sures, but does not affect their mean duration. This can
be clearly observed in the dwell time distribution as an
almost twofold reduction in the number of long events,
while the time constants of the fits are essentialliy the
same as in A (tc1 = 17 ms, tc2 = 335 ms). The traces
used for the generation of the histograms were 385 s in
A and 405 s in B.
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A
FIGURE 5 (A) The times between long gating closures increase linearly
with the procainamide concentration. According to the kinetic model pre-
sented in the text, the slope of the regression line (r = 0.85, slope = 0.056
+ 0.045 at 95% confidence, probability of nonzero slope > 0.99 (Larsen
and Marx, 1981)) represents the inverse of the equilibrium dissociation
constant for fast procainamide block. The Kd value obtained from this fit
(17.9 mM) is consistent with the results from Fig. 3 A. (B) The mean du-
ration of the long gating closures is not affected by the procainamide con-
centration (r = 0.27, slope = 0.004 ± 0.017 at 95% confidence). Closed
times were determined from fits to dwell time histograms as in Fig. 4, A and
B. Solid lines in A and B are least square fits, error bars indicate standard
deviations, dashed lines are 95% confidence intervals. Open and closed
times were determined as described under Methods. For both A and B, data
from five experiments (filled circles, 13 data points with a mean of 65 events
measured per data point) are included in the fit. The open circle indicates
a value obtained from one experiment where a stock solution of 300 mM
procainamide and 200 mM NaCl (pH 7.0) was used. This point was not
included in the fit. (C) The reduction in frequency of long gating closures
follows the same voltage dependence as fast block. Each type of symbol
(circles, upward triangles, downward triangles) represents data from one
channel. All points are single data points except for the upward triangles
which are averages from two different concentrations. The Kd for fast
block (filled symbols) is calculated from the reduction in apparent single
channel amplitude (Kd = [P]/{(I(drug free)/I) - 1}), where [P] is the pro-
cainamide concentration and I and I(drug free) are the mean baseline sub-
tracted currents in presence and absence of procainamide). Kd values
(hollow symbols) were also calculated from the reduction in long gating
events (Kd= [P]I/{(topen/topen(drug free)) - 1}; see Discussion). The volt-
age dependences of the Kd values indicate a zB of 0.38 (r = 0.93, slope
= 0.0065 ± 0.002 at 95% confidence, probability of non-zero slope
>0.99) and 0.41 (r = 0.77, slope = 0.0071+ 0.0045 at 95% confidence,
probability of non-zero slope >0.99), respectively, when calculated di-
rectly from the current reduction or from the mean time between long
gating closures. The regression line and confidence intervals shown were
calculated from the gating data. Note that the data points for fast block
are virtually identical to the data presented in Fig. 2 C, but were deter-
mined here from a different set of experiments.
(Zamponi et al., 1993a). Unlike fast block, this mode of ac-
tion was correlated with the concentration of the uncharged
form of lidocaine. This type of block occurred as a silent
burst between the long-lived closed state and the blocked
state, hence, mean times in the nonconducting state increased
with increasing lidocaine concentrations. At 20 mM procain-
amide, we did not observe this type of block. However, in
one experiment we raised the internal procainamide con-
centration to 40mM and observed an almost twofold increase
in mean closed time. In another experiment, application of
100mM procainamide to the extracellular side resulted in the
appearance of several distinct long closures which resembled
slow lidocaine blocking events. These observations suggest
that procainamide does have the ability to produce slow
block, but because of its higher pKa and its lower lipid solu-
bility than that of lidocaine, this type of block does not occur
frequently. This is consistent with the observed low potency
of fast block by external procainamide (100-fold lower than
fast externial lidocaine block), which probably also requires
diffusion of the uncharged form of the drug through a hy-
drophobic pathway.
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Inhibition of long gating closures is
voltage-dependent
If fast block and inhibition of long closures are correlated,
one would expect to detect a voltage dependence in the re-
duction of the number of long gating events which follows
the voltage dependence of fast block. Fig. 5 C compares Kd
values for fast block from three experiments at procainamide
concentrations between 6 and 40 mM. In each of these ex-
periments, we recorded at positive and negative potentials
from the same channel. The Kd values were calculated via
two different ways: 1) directly from the reduction in open
channel current amplitude (filled symbols) and 2) indirectly
from the reduction in frequency of long gating events ac-
cording to the kinetic model presented in the Discussion
(open symbols). Both the magnitudes of the Kd values and
their voltage dependences were similar when determined by
either method. Note that at each of the experiments (same
shaped symbol) the effect was less pronounced at negative
potentials (higher Kd values). For the most complete experi-
ment in which the bilayer was unusually stable (circles), we
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exposed the channel to 40 mM internal procainamide (from
the 300 mM procainamide/200 mM NaCl stock). To ensure
that the increase in intracellular ionic strength associated
with the high procainamide concentration would not affect
the channel gating, we recorded a steady state activation
curve as a control. At potentials more positive than -55 mV,
the open probability reached a plateau of 90%. Hence, at
these potentials (where there is only little voltage-dependent
gating), the increase in ionic strength on the intracellular side
did not interfere with our measurements.
Other fast blockers also prevent long gating
closures
We also observed a reduction in frequency of long gating
closures for QX-314 (three experiments). As for procain-
amide, the effect was concentration- and voltage-dependent
and was half-maximal near the Kd for fast block. At +40 mV
the Kd for QX-314 block is 3 mM (Zamponi et al., 1993a);
here we estimated 2 mM from the reduction in gating clo-
sures. In previous experiments on slow lidocaine block
(Zamponi et al., 1993b) we did not observe a consistent re-
duction in the number of long gating events. Most of these
experiments were performed at negative potentials with ex-
tracellular application of the drug at concentrations up to 6
mM. Because fast block under these conditions is weak, it
would be difficult to resolve a consistent change in mean
open times. We therefore applied 3 mM external lidocaine
at +40 mV and 21 mM external lidocaine at -40 mV (two
experiments) and observed twofold and 1.6-fold increases in
mean open time, respectively (the expected values under
these conditions would be 1.5- and 2.4-fold, respectively).
Since open times generally appear to be rather scattered (see
Fig.5 B, and companion paper (Zamponi and French, 1993)),
we consider these data to be consistent with the view that fast
lidocaine block also inhibits transitions to the long-lived
closed state. Overall, the data from all three drugs support the
idea that drug binding to the fast block receptor prevents long
gating closures.
DISCUSSION
Fast blocking actions of procainamide and
lidocaine are similar
We recently performed a detailed study on the blocking ac-
tion of lidocaine on BTX-activated cardiac and skeletal
muscle sodium channels (Zamponi et al., 1993a, b). Internal
application of lidocaine caused rapid, open-channel block
with similar properties in both cardiac and skeletal muscle
channels. The blocking rate was increased by depolarization
and the unblocking rate was increased by hyperpolarization.
For external application, the fast blocking rate was voltage-
independent, an observation which suggested that lidocaine
may find a direct hydrophobic path to the blocking site from
the extracellular side.
Procainamide appears to block via a similar mechanism.
Block is seen as rapid, flickery reduction in open-channel
current, and both the blocking and the unblocking rates show
a voltage dependence similar to those for internal lidocaine
block. Both the rat skeletal muscle and the bovine cardiac
subtype are similarly affected. For lidocaine, we obtained z6
values of 0.33 (skeletal muscle) and 0.38 (heart) for the
voltage-dependence of the Kd; here, for procainamide, the
values were 0.31 and 0.43, respectively. This supports the
idea that lidocaine and procainamide bind to one common
receptor (Sheldon et al., 1987).
When procainamide was applied from the extracellular
side of the channel, the block appeared to show a decreased
voltage sensitivity (data not shown). A loss in voltage de-
pendence of the blocking rate would be sufficient to account
for this effect which would be consistent with the idea that
external procainamide acts in the neutral form via a mecha-
nism like that proposed for external lidocaine.
Structural considerations. Why is procainamide
less potent than lidocaine?
Internal procainamide exhibits a roughly sevenfold lower
blocking affinity than lidocaine. Fast block from the internal
side appears to be caused by the charged forms of the drugs,
because it can be mimicked by permanently charged analogs,
and because raising the internal pH decreases the degree of
open channel block (Zamponi et al., 1993a; Strichartz, 1976).
However, both drugs exist predominantly in the charged
form at neutral pH. Hence, the different pKa values of li-
docaine and procainamide cannot account for the difference
in apparent Kd values for internal block.
The structures of lidocaine and procainamide differ in four
major points: 1) the aromatic ring in the lidocaine molecule
carries two methyl groups, 2) an amino group is attached to
the aromatic ring in procainamide, 3) the intermediate chain
in procainamide contains an additional methylene group, and
4) the amine-carbonyl (peptide) sequence linking the aro-
matic ring to the intermediate chain in lidocaine is reversed
in procainamide (Fig. 6 A).
Ehring et al. (1988) studied the effects of 12 out of 16
possible compounds, which were based on combinations of
these differences, on action potentials in guinea pig papillary
muscle. These investigators could not directly attribute
changes in substituents to a particular blocking behavior.
Block seemed rather to be correlated with molecular weight
or with lipid solubility determined from partition of water
into octanol (see also Courtney (1981 and 1983)). These fac-
tors, however, cannot account for our observed sevenfold
difference in Kd values for internal application, because the
molecular weights of both drugs are almost identical, and
block from the intracellular side occurs through the internal
mouth of the channel when the drugs are in the charged,
hydrophilic form. This is consistent with the conclusions of
Sheldon et al. (1991), who studied the displacement of [3H]-
batrachotoxinin A 20a-benzoate by lidocaine derivatives.
They suggested that differences in IC50 values could not
solely be attributed to partition coefficients or pKa values, but
were critically dependent on specific structural features in-
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FIGURE 6 (A) Chemical structures of lidocaine and procainamide. The voltage dependence ofblock is thought to arise from passage ofthe charged terminal
tertiary nitrogen through 30-40% of the transmembrane voltage. (B) Superposed backbone structures and space-filling models of the key inner fragments
of procainamide and lidocaine. The carbonyl 0 atoms in the aryl-amide link have been superposed for reference. The lowest energy conformer for
procainamide is shown. The alkyl chain attaching to the lidocaine tertiary amine head group has been folded to reduce to 1.53 A at the distance between
the terminal N atoms in the superposed structures. This lidocaine structure is 0.3 kcal-mol-1 higher in energy than the extended, lowest energy conformer
(not shown). Note that, the aromatic ring for lidocaine is rotated about 900 with respect to the peptide plane, whereas for procainamide the aromatic ring
and the peptide group are coplanar. The orientations of the backbone and space-filling representations are not identical. In the backbone structures, the
viewpoint is chosen so that both aromatic rings are easily identifiable; in the space-filling models, the aromatic ring of lidocaine is depicted exactly
perpendicular to the plane of the paper.
cluding the number of amino-terminal carbons and the length
of the intermediate chain (e.g., insertion of an additional
methylene group in the chain increased the IC50 by almost
twofold). In addition, sidegroups on the aromatic ring appear
to be critically involved in BTX displacement (R. Sheldon,
personal communication). Uehara and Moczydlowski (1986)
showed that procaine, which lacks the amine between the
aromatic ring and the carbonyl group, produces fast block
which is similar to procainamide block in voltage depen-
dence and potency, suggesting that the amide group in the
link between the aromatic ring and the tertiary amine head
group is not important for fast block. Overall, it seems likely
that the different binding affinities and blocking modes of
lidocaine and procainamide are directly related to specific
structural differences.
In order to explore other possible structural determinants
of drug activity, we performed molecular mechanics calcu-
lations, as described under Methods, to examine the likely
conformations of key inner fragments of the lidocaine and
procainamide structures. The low energy conformers of the
two compounds differed in two distinct ways. First, the rela-
tive orientation of the aromatic ring to the amide plane was
different by 900, with the ring in the lidocaine structure ap-
proximately perpendicular to the amide plane. The rotation
in lidocaine arises from the presence of the o-methyl groups
and resembles the structural motif common to several anti-
convulsants recently analyzed by Duke and Codding (1992).
Second, comparing the lowest energy conformation of each
compound with the carbonyl oxygen atoms superposed, the
smallest possible separation of the amine nitrogens is 3.5 A,
,CH3
B
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a difference determined primarily by an extended confor-
mation in lidocaine and a folded conformation in procain-
amide. However, a low energy folded conformer of
lidocaine-only 0.3 kcal-mol-' higher in energy than the
extended form-has a carbonyl 0 to amine N separation
similar to that found in the low energy conformer of pro-
cainamide. Fig. 6 B shows a superposition of the two similar
structures. In the figure the carbonyl oxygen atoms have been
superimposed and the molecules have been oriented to
achieve the closest possible approach of the amine N atoms,
which lie within 1.53 A of one another. The space-filling
representation of the two molecules indicates the significant
difference in space occupied by the two aromatic rings even
though the chain portions of the molecules have fair overlap.
This adjusted overlap shows that the chain portions of these
molecules could occupy the same recognition site, but, even
in that case, the aromatic rings would not both fit snugly into
the same hydrophobic pocket. This is consistent with binding
studies on stereoisomers of RAC 109 (Postma and Catterall,
1984; Hill et al., 1988) and may account for the lower po-
tency (sevenfold higher Kd, equivalent to a 1.15 kcal-mole-1
difference in binding energies) of procainamide in causing
fast block.
Data in the companion paper (Zamponi and French, 1993)
suggest that interactions of the aromatic moiety, peptide, and
the connecting chain would be strong enough to stabilize
similar conformations of lidocaine and procainamide. Fast
block by diethylamide, which represents the isolated tertiary
amine head group, is about 1/16 as potent as for lidocaine,
indicating a net stabilization of only about 1.6 kcal-mol-1 by
the combined effects of aromatic ring, peptide group, and
alkyl chain. Thus, the critical component for voltage-
dependent fast block appears to be the charged amine group.
Ancillary interactions do strengthen the binding to some ex-
tent, and they are somewhat more effective for lidocaine than
for procainamide, probably because of structural differences
illustrated in Fig. 6 B.
Reduced frequency of long gating closures of
cardiac channels is correlated with the degree of
fast block
With increasing procainamide concentration, the long gating
closures observed for BTX-activated cardiac sodium chan-
nels become less frequent, but their duration remains unaf-
fected. In the presence of procainamide, there was about a
50% reduction in the frequency of long gating closures at the
Kd for fast block. This is consistent with the idea that pro-
cainamide, when bound to the receptor responsible for fast
block, prevents long gating closures.
To test this hypothesis, we isolated the long closed events
from fast block and fast gating closures by heavily filtering
the records (25 Hz) and ignoring closed events shorter than
70 ms. Thus, in absence of the blocker, true openings and
short closures are lumped together into one open state, 0
(mean duration, topen(drug free)), and only long gating events
are seen as closures (mean duration, tC2). Procainamide adds
an additional kinetic state (Bf). However, in our analysis of
the slow closures, Bf becomes part of the "open" state (mean
duration, topen, see Eq. 1). Our analysis assumes that the rates
a and a are not affected by the presence of procainamide and
does not consider contributions from fast gating events, be-
cause at +40mV they are short, and are infrequent compared
with the blocking transitions. We have used similar assump-
tions to analyze slow lidocaine block (Zamponi et al.,
1993b). Hence, we consider the following linear three state
model:
y[P] a
Bf ± O ± C2
8 3 (1)
topen
Transitions to the closed state C2 are only permitted from the
true open state (0). Since the transition from the open to the
fast blocked state (Bf) is concentration-dependent, procain-
amide shifts the equilibrium away from the closed state C2
and toward the blocked state Bf, resulting in fewer closures
and an increase in topen. This concentration-dependent in-
crease is described by the relation:
topen = (n + l)topen(drug free) + (n)tbf,
where n is the number of transitions between the true open
state (0) and the fast blocked state (Bf). According to
Colqhoun and Ogden (1988),
n = [P]/a,
where [P] is the procainamide concentration. Since
a = 1/topen(drug free)
and
8- open ~~~~=1 + (~[PI].
a=f topen(drug free) 8
Plotting this relation against procainamide concentration
yields a straight line with an intercept at 1 and a slope equiva-
lent to 1/Kd for fast procainamide block. This plot is the basis
for Fig. 5 A. Consistent with our kinetic scheme, the Kd
obtained from the regression line (17.9 mM) is close to the
Kd for fast block (14.9 mM).
If our model is correct, one would also expect the reduc-
tion in gating closures to follow the same voltage dependence
as fast block. We observed a qualitatively weaker inhibition
of long closures at negative potentials in four experiments.
For three of these experiments a quantitative analysis was
warranted. As can be seen from Fig. 5 C, the voltage de-
pendence of the reduction in the frequency of long gating
closures was similar to that of fast block. We obtained elec-
trical distances of 0.38 and 0.41 for the voltage dependences
of fast block and reduction in the number of long gating
events, respectively. These data are consistent with the value
obtained from Fig. 2 C and provide further evidence for our
proposed kinetic model.
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We did not devote a detailed study to the effects of QX-314
on the frequency of the long gating closures. However, ob-
servations that the effect was voltage-dependent, increased
with QX-314 concentration, and was half-maximal near the
Kd for QX-314 block (Kd = 6.4mM at 0 mV (Zamponi et al.,
1993a)) suggest a similar correlation between the fast block-
ing action of QX-314 and the inhibition of long gating clo-
sures. Together with our observations on lidocaine and di-
ethylamide (see companion paper), our data suggest that drug
binding to the fast blocking site causes the inhibition of long
closures, i.e., of the residual inactivation seen in BTX-
modified cardiac channels.
So far, most studies on procainamide have dealt with the
effects of the drug on whole cell action potentials (e.g.,
Rosen et al., 1972; 1973; Arnsdorf and Bigger, 1975).
These authors reported a shortening of the action potential
after application of lidocaine or procainamide, as well as a
reduction in (dV/dt)max. Carmeliet and Saikawa (1981)
suggested that this effect was due to block of sodium, and
not potassium currents. However, we could not find any
data on procainamide action at the single channel level. It
is, thus, difficult to view all of our results in context of the
effects observed on action potentials. The procainamide-
induced open channel block reported here would be con-
sistent with a reduction in the inward sodium current dur-
ing the initial depolarizing phase of the cardiac action
potential (e.g., Rosen et al., 1972). However, we are un-
able to state whether the antagonizing effect of procain-
amide on inactivation observed in our experiments is sig-
nificant under physiological conditions, because few data
are available on the effects on procainamide on isolated
sodium currents. Investigating the action of procainamide
on unmodified, single sodium channels or whole cell so-
dium currents should help to clarify the interactions of pro-
cainamide with the inactivated state.
CONCLUSIONS
We have investigated the interactions between procainamide
and BTX-activated sodium channels from heart and skeletal
muscle. When internally applied, procainamide causes
voltage-dependent open channel block which is similar for
both subtypes. Block from the outside is weak, because it
possibly requires direct hydrophobic access to the binding
site, and procainamide is present predominantly in the
charged form. In cardiac channels, fast block by procain-
amide appears to prevent long duration closures thought to
be a residual inactivation of the BTX-modified channels.
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